Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...

Ocugen Inc (($OCGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Ocugen Inc. recently held its earnings call, ...

The management of advanced thyroid cancer requires careful consideration of histology, molecular profiling, and treatment ...

For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of the medicinal product.

The gene p53 acts as a tumor suppressor and is often called the guardian of the genome. This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to ...

Pfizer and Novo Nordisk continue to fight for ownership of obesity startup Metsera; CDER Director George Tidmarsh leaves his ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ But when p53 mutates, it can flip from protector to promoter of cancer. Gene p53 is mutated in about 50% of ...

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

The agency is establishing a network of care centers to expand access to regenerative medicine beyond regions served by major ...

AVALA Hospital and Retina Associates perform Louisiana’s first ENCELTO procedure, offering new gene therapy treatment for ...

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...